Clinical Value of Single-Projection Angiography–Derived FFR in Noninfarct-Related Artery

Author:

Kwon Woochan1ORCID,Choi Ki Hong1ORCID,Lee Seung Hun2ORCID,Hong David1ORCID,Shin Doosup3ORCID,Kim Hyun Kuk4ORCID,Park Keun Ho4ORCID,Choo Eun Ho5ORCID,Kim Chan Joon6,Kim Min Chul2ORCID,Hong Young Joon2ORCID,Ahn Sung Gyun7ORCID,Doh Joon-Hyung8ORCID,Lee Sang Yeub9ORCID,Park Sang Don10ORCID,Lee Hyun-Jong11ORCID,Kang Min Gyu12ORCID,Koh Jin-Sin12ORCID,Cho Yun-Kyeong13ORCID,Nam Chang-Wook13ORCID,Joh Hyun Sung14ORCID,Kyu Park Taek1ORCID,Yang Jeong Hoon1ORCID,Song Young Bin1ORCID,Choi Seung-Hyuk1ORCID,Jeong Myung Ho2,Gwon Hyeon-Cheol1ORCID,Hahn Joo-Yong1ORCID,Lee Joo Myung1ORCID,

Affiliation:

1. Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea (W.K., K.H.C., D.H., T.K.P., J.H.Y., Y.B.S., S.-H.C., H.-C.G., J.-Y.H., J.M.L.).

2. Division of Cardiology, Department of Internal Medicine, Heart Center, Chonnam National University Hospital, Chonnam National University Medical School, Gwangju, South Korea (S.H.L., M.C.K., Y.J.H., M.H.J.).

3. Division of Cardiology, Department of Internal Medicine, Duke University Medical Center, Durham, NC (D.S.).

4. Chosun University Hospital, University of Chosun College of Medicine, Gwangju, South Korea (H.K.K., K.H.P.).

5. Seoul St. Mary’s Hospital, The Catholic University of Korea, South Korea (E.H.C.).

6. The Catholic University of Korea, Uijeongbu St. Mary’s Hospital, Seoul, South Korea (C.J.K.).

7. Yonsei University Wonju College of Medicine, Wonju Severance Christian Hospital, South Korea (S.G.A.).

8. Department of Medicine, Inje University Ilsan Paik Hospital, Goyang, South Korea (J.-H.D.).

9. Chung-Ang University College of Medicine, Chung-Ang University Gwangmyeong Hospital, South Korea (S.Y.L.).

10. Inha University Hospital, Incheon, South Korea (S.D.P.).

11. Sejong General Hospital, Bucheon, South Korea (H.-J.L.).

12. Gyeongsang National University School of Medicine, Gyeongsang National University Hospital, Jinju, South Korea (M.G.K., J.-S.K.).

13. Keimyung University Dongsan Medical Center, Daegu, South Korea (Y.-K.C., C.-W.N.).

14. Seoul National University Boramae Medical Center, Seoul National University College of Medicine, South Korea (H.S.J.).

Abstract

BACKGROUND: The Murray law–based quantitative flow ratio (μFR) is an emerging technique that requires only 1 projection of coronary angiography with similar accuracy to quantitative flow ratio (QFR). However, it has not been validated for the evaluation of noninfarct-related artery (non-IRA) in acute myocardial infarction (AMI) settings. Therefore, our study aimed to evaluate the diagnostic accuracy of μFR and the safety of deferring non-IRA lesions with μFR >0.80 in the setting of AMI. METHODS: μFR and QFR were analyzed for non-IRA lesions of patients with AMI enrolled in the FRAME-AMI trial (Fractional Flow Reserve Versus Angiography-Guided Strategy for Management of Non-Infarction Related Artery Stenosis in Patients With Acute Myocardial Infarction), consisting of fractional flow reserve (FFR)–guided percutaneous coronary intervention and angiography-guided percutaneous coronary intervention groups. The diagnostic accuracy of μFR was compared with QFR and FFR. Patients were classified by the non-IRA μFR value of 0.80 as a cutoff value. The primary outcome was a vessel-oriented composite outcome, a composite of cardiac death, non-IRA–related myocardial infarction, and non-IRA–related repeat revascularization. RESULTS: μFR and QFR analyses were feasible in 443 patients (552 lesions). μFR showed acceptable correlation with FFR (R=0.777; P <0.001), comparable C-index with QFR to predict FFR ≤0.80 (μFR versus QFR: 0.926 versus 0.961, P =0.070), and shorter total analysis time (mean, 32.7 versus 186.9 s; P <0.001). Non-IRA with μFR >0.80 and deferred percutaneous coronary intervention had a significantly lower risk of vessel-oriented composite outcome than non-IRA with performed percutaneous coronary intervention (3.4% versus 10.5%; hazard ratio, 0.37 [95% CI, 0.14–0.99]; P =0.048). CONCLUSIONS: In patients with multivessel AMI, μFR of non-IRA showed acceptable diagnostic accuracy comparable to that of QFR to predict FFR ≤0.80. Deferred non-IRA with μFR >0.80 showed a lower risk of vessel-oriented composite outcome than revascularized non-IRA. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT02715518.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3